The Vexing Problems of Vaccine Compensation
Science. 1985 Mar 1; 227(4690): 1012-1014.
Debate continues in the United States over the best way to compensate children who are injured by vaccines administered as part of the public health campaign against childhood diseases. Blaming increased liability costs, several drug companies have stopped production of essential vaccines, raising fears of shortages. Proposals that the federal government sponsor a compensation system have met with approval from parents of injured children, medical associations, and drug companies, although these groups disagree over whether victims should retain the right to sue the vaccine manufacturers as an alternative to receiving federal compensation. Legislation has been introduced in both houses of Congress to establish a compensation program, but Administration opposition is expected to the potential expense and the broad range of coverage. (KIE abstract)
Showing items related by title, author, creator and subject.